Tyler Novotny is Senior Vice President at the Drug Channels Institute (DCI), where he focuses on building sustainable long-term value for DCI and its audience. Prior to joining DCI, he spent 12 years at Cencora, most recently serving as Vice President of Market Economics. In that role, he specialized in policy risk sizing, drug pricing dynamics, and developing novel strategies and solutions to address evolving pharmaceutical market challenges.

Tyler holds a bachelor’s degree from the University of Pittsburgh and an MBA from Villanova University.